Broad spectrum preclinical antitumor activity of eribulin (Halaven(R)): optimal effectiveness under intermittent dosing conditions.
Year: 2012
Type: article
Source: PubMed
Authors: Murray J Towle, Kenichi Nomoto, Makoto Asano, Yoshito Kishi, Melvin J Yu, Bruce A Littlefield
Institution: Eisai (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: eribulin, halichondrin B analog, microtubule dynamics inhibitor, anticancer activity, dosing regimen, intermittent dosing, tumor xenografts, maximum tolerated dose, tumor growth inhibition, biomarkers, metastatic breast cancer, fibrosarcoma, glioblastoma, non-small cell lung cancer, small cell lung cancer
Open Access status: closed
OpenAlex ID: W2142499705
